MedPath

Pfizer Europe MA EEIG

🇬🇧United Kingdom
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

349

CIMA_AEMPS:169
NMPA:70
EMA:67
+1 more agencies

Drug Approvals

Talazoparib Tosylate Capsules

Product Name
泰泽纳
Approval Number
国药准字HJ20240124
Approval Date
Oct 29, 2024
NMPA

Talazoparib Tosylate Capsules

Product Name
泰泽纳
Approval Number
国药准字HJ20240122
Approval Date
Oct 29, 2024
NMPA

Talazoparib Tosylate Capsules

Product Name
泰泽纳
Approval Number
国药准字HJ20240123
Approval Date
Oct 29, 2024
NMPA

Talazoparib Tosylate Capsules

Product Name
泰泽纳
Approval Number
国药准字HJ20240121
Approval Date
Oct 29, 2024
NMPA

Axitinib Tablets

Product Name
英立达
Approval Number
国药准字HJ20150219
Approval Date
Aug 19, 2024
NMPA

Axitinib Tablets

Product Name
英立达
Approval Number
国药准字HJ20150221
Approval Date
Aug 19, 2024
NMPA

Axitinib Tablets

Product Name
英立达
Approval Number
国药准字HJ20150220
Approval Date
Aug 19, 2024
NMPA

Axitinib Tablets

Product Name
英立达
Approval Number
国药准字HJ20150222
Approval Date
Aug 19, 2024
NMPA

Tafamidis Meglumine Soft Capsules

Product Name
维达全
Approval Number
国药准字HJ20200001
Approval Date
Jun 28, 2024
NMPA

Etanercept Solution for Injection

Product Name
恩利
Approval Number
国药准字SJ20170048
Approval Date
Jun 6, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.